through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
Introduction For decades, lung function testing has relied heavily on spirometry—a test that requires patients to perform forceful, maximal expiratory maneuvers. While effective, spirometry presents significant challenges: young chi...
What Is COPD? Chronic obstructive pulmonary disease, commonly known as COPD, is a progressive lung condition in which the airways become inflamed and narrowed, and the air sacs become damaged. This damage makes it increasingly difficult t...
ERS 2026
Please complete the form to contact our team